Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer (2023)

First Author: Lambertini M
Attributed to:  MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6004/jnccn.2022.7065

PubMed Identifier: 36634607

Publication URI: http://europepmc.org/abstract/MED/36634607

Type: Journal Article/Review

Parent Publication: Journal of the National Comprehensive Cancer Network

Issue: 1

ISSN: 1540-1405